Amplitude Surgical SA (0RAF.L)
| Previous close | 0.0000 |
| Open | 0.0000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.0000 - 0.0000 |
| 52-week range | |
| Volume | |
| Avg. volume | N/A |
| Market cap | 1.097M |
| Beta (5Y monthly) | 0.61 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Amplitude Surgical – First Quarter 2022-23: Consolidated Sales of €19.4 Million, +11.3% at Constant Exchange Rates
VALENCE, France, November 24, 2022--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME equity savings plans) (Paris:AMPLI), a leading French player on the surgical technology market for lower-limb orthopedics, announces its sales for the first quarter of its 2022-23 financial year.
- Business Wire
Amplitude Surgical Announces Its 2022-23 Financial Calendar
VALENCE, France, November 24, 2022--Regulatory News: Amplitude Surgical (ISIN : FR0012789667, Mnémo : AMPLI, PEA-PME eligible) (Paris:AMPLI), ("Amplitude" or the "Group"), French leader on the global surgical technology market for lower-limb orthopedics, announces its 2022-23 financial calendar.
- Business Wire
Amplitude Surgical – 2021-22 Annual Results: Sales of €87.6m and EBITDA of €22.0m
VALENCE, France, October 19, 2022--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME equity savings plans) (Paris:AMPLI), a leading French player on the surgical technology market for lower-limb orthopedics, announces its 2021-22 annual results.
